MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.740
-0.270 (-13.43%)
At close: Jun 12, 2026, 4:00 PM EDT
1.660
-0.080 (-4.60%)
Pre-market: Jun 15, 2026, 4:58 AM EDT
MetaVia Market Cap
MetaVia has a market cap or net worth of $8.99 million as of June 12, 2026. Its market cap has decreased by -32.67% in one year.
Market Cap
8.99M
Enterprise Value
-4.55M
1-Year Change
-32.67%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since December 31, 2019, MetaVia's market cap has decreased from $104.41B to $8.99M, a decrease of -99.99%. That is a compound annual growth rate of -76.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 8.99M | -51.52% |
| Dec 31, 2025 | 18.54M | 5.97% |
| Dec 31, 2024 | 17.49M | -2.47% |
| Dec 29, 2023 | 17.93M | 31.75% |
| Dec 30, 2022 | 13.61M | -58.04% |
| Dec 31, 2021 | 32.44M | -62.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioCardia | 10.01M |
| Intensity Therapeutics | 9.59M |
| Kairos Pharma | 9.42M |
| HCW Biologics | 9.17M |
| Curanex Pharmaceuticals | 9.11M |
| BioRestorative Therapies | 8.98M |
| Bolt Biotherapeutics | 8.76M |
| Aprea Therapeutics | 8.50M |